Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level.
暂无分享,去创建一个
Arch G Mainous | Dana E King | A. Mainous | R. Woolson | B. Egan | D. King | Ammar Jesri | Brent M Egan | Robert F Woolson | Yaser Al-Solaiman | Ammar Jesri | Yaser Al-Solaiman
[1] B. Egan,et al. Relation of dietary fat and fiber to elevation of C-reactive protein. , 2003, The American journal of cardiology.
[2] Nancy R Cook,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.
[3] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[4] Ose,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .
[5] A. Aljada,et al. Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .
[6] P. Ridker,et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.
[7] Nancy R Cook,et al. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.
[8] L. V. Van Horn. Fiber, lipids, and coronary heart disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1997, Circulation.
[9] A. Mainous,et al. Fiber and C-reactive protein in diabetes, hypertension, and obesity. , 2005, Diabetes care.
[10] D. King. Dietary fiber, inflammation, and cardiovascular disease. , 2005, Molecular nutrition & food research.
[11] L. Horn. Fiber, Lipids, and Coronary Heart Disease A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association , 1997 .
[12] Alessandro Pontillo,et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.
[13] A. Willan,et al. Carryover and the two-period crossover clinical trial. , 1986, Biometrics.
[14] A. Poullis,et al. Bowel Inflammation as Measured by Fecal Calprotectin , 2004, Cancer Epidemiology Biomarkers & Prevention.
[15] K. Sung,et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. , 2004, International journal of cardiology.
[16] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[17] P. Ridker,et al. C-reactive protein and the risk of developing hypertension. , 2003, JAMA.
[18] C Guijarro,et al. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.
[19] E. Ford. Body mass index, diabetes, and C-reactive protein among U.S. adults. , 1999, Diabetes care.
[20] D. Giugliano,et al. Diet and inflammation: a link to metabolic and cardiovascular diseases. , 2006, European heart journal.
[21] S. Devaraj,et al. ATVB In Focus Nutrition and Atherosclerosis , 2006 .
[22] P. Macfarlane,et al. The prognostic value of the electrocardiogram in the west of Scotland coronary prevention study , 2002 .